~~<i id='C11599807D'><strike id='C11599807D'><tt id='C11599807D'><pre id='C11599807D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：fashion 2025-09-05 13:32:47 - browse：9567

Photo illustration of a single pill on a large white field – opinion coverage from STAT — Adobe

This time last year, members of Congress were working around the clock to draft and pass the Inflation Reduction Act.

One of their goals was to address government spending on health care. But they specifically didn’t want to discourage research into rare disease treatments, so they exempted some of these so-called orphan drugs from the law.

Unfortunately, the exemptions aren’t working as intended. Unless Congress acts, the IRA threatens to unravel one of America’s greatest medical and public policy success stories: the explosion of new treatments for patients living with rare diseases.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Behind warning on Apellis’s eye drug lies a conflict of interest

explore

knowledge

leisure time

hotspot

focus

7:06AphotocontainedintheindictmentreleasedonJune9,2023,fromtheU.S.SouthernDistrictofFlorida,showsbox

WSS

Stoke drug shows lower activity against childhood epilepsy

As biotech industry slumps, bioscience job market is upside down

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Mayo Clinic plans $5B tech

focus

hotspot

explore

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Takeda, Janssen join wearable maker to measure scratching

United colonoscopy coverage change 'may cost lives,' doctors say

Ford recalls 870K F

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Organ aging and disease risk measured by new blood test

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA investigates CAR

United colonoscopy coverage change 'may cost lives,' doctors say

The mammogram wars are not over

knowledge

Will the market for weight loss drugs really reach $100 billion?

Takeda, Janssen join wearable maker to measure scratching

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Despite FDA concern, risk that CAR

Marc Tessier

Flagship Pioneering launches a new biotech in two countries

leisure time

leisure time

hotspot

focus